2021 BSG/ESGE威廉亚洲博彩公司：抗血小板或抗凝治疗患者的内镜检查（更新版）

2021-08-02 英国胃肠病学会 Gut.2021 Sep;70(9):1611-1628.

2021年，英国胃肠病学会(BSG)联合欧洲胃肠道内窥镜学会(ESGE)更新发布了抗血小板或抗凝治疗患者的内镜检查威廉亚洲博彩公司。该威廉亚洲博彩公司是对2016年版威廉亚洲博彩公司的更新，威廉亚洲博彩公司对内镜手术的风险类别和血栓形成风险类别进行

中文标题：

英文标题：

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

发布机构：

英国胃肠病学会

发布日期：

2021-08-02

简要介绍：

2021年，英国胃肠病学会(BSG)联合欧洲胃肠道内窥镜学会(ESGE)更新发布了抗血小板或抗凝治疗患者的内镜检查威廉亚洲博彩公司。该威廉亚洲博彩公司是对2016年版威廉亚洲博彩公司的更新，威廉亚洲博彩公司对内镜手术的风险类别和血栓形成风险类别进行修订，增加了关于急性胃肠道出血患者的管理内容并强调了重要换值得注意事项。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=546151c00215a4db, title=2021 BSG/ESGE威廉亚洲博彩公司：抗血小板或抗凝治疗患者的内镜检查（更新版）, enTitle=Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update, guiderFrom=Gut.2021 Sep;70(9):1611-1628., authorId=0, author=, summary=2021年，英国胃肠病学会(BSG)联合欧洲胃肠道内窥镜学会(ESGE)更新发布了抗血小板或抗凝治疗患者的内镜检查威廉亚洲博彩公司。该威廉亚洲博彩公司是对2016年版威廉亚洲博彩公司的更新，威廉亚洲博彩公司对内镜手术的风险类别和血栓形成风险类别进行, cover=https://img.medsci.cn/2021815/1629013535422_2020535.jpg, journalId=0, articlesId=null, associationId=265, associationName=英国胃肠病学会, associationIntro=英国胃肠病学会（The British Society of Gastroenterology，BSG）专注于提升英国胃肠病学医疗水平，其涉及内科、外科、病理、放射、科学、护理、营养等领域。威廉亚洲博彩公司可以按日期、及专科浏览。, copyright=0, guiderPublishedTime=Mon Aug 02 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年，英国胃肠病学会(BSG)联合欧洲胃肠道内窥镜学会(ESGE)更新发布了抗血小板或抗凝治疗患者的内镜检查威廉亚洲博彩公司。该威廉亚洲博彩公司是对2016年版威廉亚洲博彩公司的更新，威廉亚洲博彩公司对内镜手术的风险类别和血栓形成风险类别进行修订，增加了关于急性胃肠道出血患者的管理内容并强调了重要换值得注意事项。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=836, tagName=抗血小板), TagDto(tagId=5096, tagName=内镜检查)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=5096, guiderKeyword=内镜检查, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=威廉亚洲博彩公司 , guiderLanguage=0, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6283, appHits=173, showAppHits=0, pcHits=1031, showPcHits=6109, likes=2, shares=13, comments=6, approvalStatus=1, publishedTime=Sun Aug 15 16:06:33 CST 2021, publishedTimeString=2021-08-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Aug 15 15:45:41 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 20:21:25 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 BSG_ESGE威廉亚洲博彩公司：抗血小板或抗凝治疗患者的内镜检查（更新版）.pdf)])

2021 BSG_ESGE威廉亚洲博彩公司：抗血小板或抗凝治疗患者的内镜检查（更新版）.pdf

下载请点击：

评论区 (6)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2101258, encodeId=17162101258e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3ed6471375, createdName=ms5000001165770558, createdTime=Fri Nov 18 08:58:51 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082361, encodeId=936510823615f, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:42:09 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062548, encodeId=c7661062548bb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEK3TQvnP74Q2JsVzgN9iaWLvcGH4vNg9piaLqpW8m88yk4ict5xcf4LAOyGq6Oicy410VykSdsOmT8uhg/132, createdBy=766e2511801, createdName=NeilAspx, createdTime=Thu Oct 21 11:40:50 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057617, encodeId=ee88105e61720, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a155600872, createdName=ms6000000298623125, createdTime=Mon Oct 04 16:22:21 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008813, encodeId=94ce1008813fc, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/79787990fd4d410da13321cd9d24e82e/1a10fd45711f4729a717d387ae168480.jpg, createdBy=9f355541150, createdName=变ms2000001668246797, createdTime=Tue Aug 17 20:12:10 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
2022-11-18 ms5000001165770558

学习

73 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=2101258, encodeId=17162101258e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3ed6471375, createdName=ms5000001165770558, createdTime=Fri Nov 18 08:58:51 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082361, encodeId=936510823615f, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:42:09 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062548, encodeId=c7661062548bb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEK3TQvnP74Q2JsVzgN9iaWLvcGH4vNg9piaLqpW8m88yk4ict5xcf4LAOyGq6Oicy410VykSdsOmT8uhg/132, createdBy=766e2511801, createdName=NeilAspx, createdTime=Thu Oct 21 11:40:50 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057617, encodeId=ee88105e61720, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a155600872, createdName=ms6000000298623125, createdTime=Mon Oct 04 16:22:21 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008813, encodeId=94ce1008813fc, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/79787990fd4d410da13321cd9d24e82e/1a10fd45711f4729a717d387ae168480.jpg, createdBy=9f355541150, createdName=变ms2000001668246797, createdTime=Tue Aug 17 20:12:10 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
2021-12-21 龙珠

学习好资料！

87 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=2101258, encodeId=17162101258e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3ed6471375, createdName=ms5000001165770558, createdTime=Fri Nov 18 08:58:51 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082361, encodeId=936510823615f, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:42:09 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062548, encodeId=c7661062548bb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEK3TQvnP74Q2JsVzgN9iaWLvcGH4vNg9piaLqpW8m88yk4ict5xcf4LAOyGq6Oicy410VykSdsOmT8uhg/132, createdBy=766e2511801, createdName=NeilAspx, createdTime=Thu Oct 21 11:40:50 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057617, encodeId=ee88105e61720, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a155600872, createdName=ms6000000298623125, createdTime=Mon Oct 04 16:22:21 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008813, encodeId=94ce1008813fc, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/79787990fd4d410da13321cd9d24e82e/1a10fd45711f4729a717d387ae168480.jpg, createdBy=9f355541150, createdName=变ms2000001668246797, createdTime=Tue Aug 17 20:12:10 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
2021-10-21 NeilAspx

学习

107 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=2101258, encodeId=17162101258e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3ed6471375, createdName=ms5000001165770558, createdTime=Fri Nov 18 08:58:51 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082361, encodeId=936510823615f, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:42:09 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062548, encodeId=c7661062548bb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEK3TQvnP74Q2JsVzgN9iaWLvcGH4vNg9piaLqpW8m88yk4ict5xcf4LAOyGq6Oicy410VykSdsOmT8uhg/132, createdBy=766e2511801, createdName=NeilAspx, createdTime=Thu Oct 21 11:40:50 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057617, encodeId=ee88105e61720, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a155600872, createdName=ms6000000298623125, createdTime=Mon Oct 04 16:22:21 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008813, encodeId=94ce1008813fc, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/79787990fd4d410da13321cd9d24e82e/1a10fd45711f4729a717d387ae168480.jpg, createdBy=9f355541150, createdName=变ms2000001668246797, createdTime=Tue Aug 17 20:12:10 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
2021-10-04 ms6000000298623125

不错

106 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=2101258, encodeId=17162101258e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3ed6471375, createdName=ms5000001165770558, createdTime=Fri Nov 18 08:58:51 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082361, encodeId=936510823615f, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:42:09 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062548, encodeId=c7661062548bb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEK3TQvnP74Q2JsVzgN9iaWLvcGH4vNg9piaLqpW8m88yk4ict5xcf4LAOyGq6Oicy410VykSdsOmT8uhg/132, createdBy=766e2511801, createdName=NeilAspx, createdTime=Thu Oct 21 11:40:50 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057617, encodeId=ee88105e61720, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a155600872, createdName=ms6000000298623125, createdTime=Mon Oct 04 16:22:21 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008813, encodeId=94ce1008813fc, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/79787990fd4d410da13321cd9d24e82e/1a10fd45711f4729a717d387ae168480.jpg, createdBy=9f355541150, createdName=变ms2000001668246797, createdTime=Tue Aug 17 20:12:10 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
2021-08-17 变ms2000001668246797

厉害

106 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

消化威廉亚洲博彩公司

2021 BSG/ESGE威廉亚洲博彩公司：抗血小板或抗凝治疗患者的内镜检查（更新版）

相关威廉亚洲博彩公司

拓展阅读

科室

工具

服务

消化威廉亚洲博彩公司

2021 BSG/ESGE威廉亚洲博彩公司 ：抗血小板或抗凝治疗患者的内镜检查（更新版）

相关威廉亚洲博彩公司

拓展阅读

科室

工具

服务

2021 BSG/ESGE威廉亚洲博彩公司：抗血小板或抗凝治疗患者的内镜检查（更新版）